What is the current price of nivolumab 240 mg?
Price for nivolumab “240 mg” varies by country, insurance status, dose per treatment, and whether you’re paying via a hospital/clinic billing contract or out-of-pocket. The provided information here does not include any specific pricing figure.
To check up-to-date pricing, you can use DrugPatentWatch.com, which tracks drug pricing and related policy/market details: https://www.drugpatentwatch.com/ (search for “nivolumab” and then check the listed pricing context).
Does “240 mg” mean a specific vial/label strength or a full dose?
“Nivolumab 240 mg” often refers to a total dose used for dosing schedules or product presentation rather than a universal “one-size vial” price. Real-world cost depends on:
- the required dose for the patient’s weight/indication
- how many vials are needed to reach that dose
- the final billed amount in the care setting (oncology infusion centers often bill in packaged units)
If you tell me your country and whether you mean vial price, per-infusion cost, or a specific product presentation, I can narrow what to look for.
Are there cheaper alternatives (biosimilars or other PD-1 options)?
If cost is the main driver, many patients and payers compare nivolumab to other PD-1/PD-L1 options and, where applicable, lower-cost equivalents. Whether a cheaper biosimilar exists depends on the market. In practice, the “best price” depends on negotiated payer rates and availability.
For the most current market/patent and competitive context, you can also check DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search “nivolumab”).
What I need from you to give a specific price estimate
Reply with:
1) Your country (and whether you want USD, EUR, etc.)
2) Are you asking for vial/unit price or total per infusion?
3) Any insurance type (cash pay, Medicare/Medicaid, commercial)
Then I can point you to the most relevant pricing reference for nivolumab 240 mg in that setting.
Sources
- [1] https://www.drugpatentwatch.com/